Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 10, Pages 2349-2358
Publisher
Wiley
Online
2012-10-10
DOI
10.1002/ijc.27894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
- (2012) Yvonne Nadine Fahmueller et al. BMC CANCER
- Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy
- (2012) Nikolaus Kohles et al. TUMOR BIOLOGY
- Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study
- (2011) L. Jiao et al. CANCER RESEARCH
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy
- (2010) Oliver Dudeck et al. EUROPEAN RADIOLOGY
- Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer
- (2010) S-C Wang et al. Journal of Medical Imaging and Radiation Oncology
- Radioembolization of Liver Tumors With Yttrium-90 Microspheres
- (2010) Hojjat Ahmadzadehfar et al. SEMINARS IN NUCLEAR MEDICINE
- Immunogenic cell death modalities and their impact on cancer treatment
- (2009) Oliver Kepp et al. APOPTOSIS
- Selective Internal Radiation Therapy with SIR-Spheres for the Treatment of Unresectable Colorectal Hepatic Metastases
- (2009) Roberto Cianni et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Clinical use of circulating nucleosomes
- (2009) Stefan Holdenrieder et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease—Is it feasible?
- (2009) R.T. Hoffmann et al. EUROPEAN JOURNAL OF RADIOLOGY
- Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.
- (2009) Wojciech Naumnik et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- HMGB1 loves company
- (2009) Marco E. Bianchi JOURNAL OF LEUKOCYTE BIOLOGY
- Assessing Tumor Response to Therapy
- (2009) W. A. Weber JOURNAL OF NUCLEAR MEDICINE
- Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
- (2009) Hye Chung et al. Journal of Translational Medicine
- RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
- (2009) Louis J Sparvero et al. Journal of Translational Medicine
- Yttrium-90 Radioembolization for Liver Malignancies: Prognostic Factors Associated with Survival
- (2009) Brian L. Dunfee et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
- (2009) Guan-Hong Shang et al. RESPIRATORY MEDICINE
- Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update
- (2008) S. H. Beachy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies
- (2008) L. Apetoh et al. CANCER RESEARCH
- Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
- (2008) S. Holdenrieder et al. CLINICAL CANCER RESEARCH
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
- (2008) Vilma Urbonaviciute et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer
- (2008) Stefan Holdenrieder et al. LUNG CANCER
- Multimodality Imaging Following90Y Radioembolization: A Comprehensive Review and Pictorial Essay
- (2008) Bassel Atassi et al. RADIOGRAPHICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started